MRC1 and neoplasm: Functionally, these MHCII−/CD206+ macrophages act as tumor-supportive macrophages through inhibition of anti-tumor immunity, as well as through promotion of vessel formation by secretion of angiogenic factors and initiation of metastasis through matrix remodeling [22–26].